Stock On Watch: Today Metlife Inc Stock Rises

Stock On Watch: Today Metlife Inc Stock Rises

The stock of Metlife Inc (NYSE:MET) is a huge mover today! About 7.27 million shares traded hands or 5.21% up from the average. Metlife Inc (NYSE:MET) has risen 8.49% since March 3, 2016 and is uptrending. It has outperformed by 0.15% the S&P500.
The move comes after 9 months positive chart setup for the $52.64B company. It was reported on Oct, 6 by We have $66.37 PT which if reached, will make NYSE:MET worth $22.11B more.

Analysts await Metlife Inc (NYSE:MET) to report earnings on November, 2. They expect $1.28 earnings per share, up 106.45% or $0.66 from last year’s $0.62 per share. MET’s profit will be $1.44B for 9.13 P/E if the $1.28 EPS becomes a reality. After $0.83 actual earnings per share reported by Metlife Inc for the previous quarter, Wall Street now forecasts 54.22% EPS growth.

Metlife Inc (NYSE:MET) Ratings Coverage

Out of 12 analysts covering MetLife (NYSE:MET), 8 rate it a “Buy”, 0 “Sell”, while 4 “Hold”. This means 67% are positive. MetLife has been the topic of 15 analyst reports since July 31, 2015 according to StockzIntelligence Inc. The rating was downgraded by Citigroup to “Neutral” on Tuesday, January 5. Deutsche Bank maintained it with “Buy” rating and $62 target price in Friday, July 31 report. The firm has “Strong Buy” rating by Raymond James given on Friday, January 22. As per Friday, September 23, the company rating was reinitiated by Wells Fargo. The stock of Metlife Inc (NYSE:MET) earned “Equal-Weight” rating by Morgan Stanley on Wednesday, November 11. The firm earned “Outperform” rating on Thursday, January 14 by Macquarie Research. The firm has “Buy” rating given on Monday, June 27 by Sandler O’Neill. The stock of Metlife Inc (NYSE:MET) has “Hold” rating given on Wednesday, July 13 by Deutsche Bank. FBR Capital maintained the shares of MET in a report on Monday, August 29 with “Outperform” rating. The stock has “Outperform” rating given by RBC Capital Markets on Tuesday, January 19.

According to Zacks Investment Research, “Metlife Inc. is a leading provider of insurance and financial services to a broad spectrum of individual and institutional customers. The company currently provides individual insurance, annuities and investment products. The company also provides group insurance and retirement and savings products and services to corporations and other institutions. The company believes that their unparalleled franchises and brand names uniquely position them to be the preeminent provider of insurance and financial services in the U.S.”

Insitutional Activity: The institutional sentiment increased to 1.04 in 2016 Q2. Its up 0.01, from 1.03 in 2016Q1. The ratio increased, as 55 funds sold all Metlife Inc shares owned while 343 reduced positions. 81 funds bought stakes while 334 increased positions. They now own 797.11 million shares or 0.92% less from 804.49 million shares in 2016Q1.
Hgk Asset Mgmt accumulated 394,690 shares or 2.35% of the stock. Mesirow Invest Mngmt holds 0.03% of its portfolio in Metlife Inc (NYSE:MET) for 14,519 shares. Nuveen Asset Mngmt Ltd Co last reported 0.03% of its portfolio in the stock. Hbk Invs Lp owns 16,693 shares or 0.01% of their US portfolio. Cubist Systematic Strategies Ltd Liability Com has invested 0.11% of its portfolio in Metlife Inc (NYSE:MET). Supplemental Annuity Collective Tru Of Nj has 0.37% invested in the company for 18,656 shares. The Pennsylvania-based Smithbridge Asset Management De has invested 2.06% in Metlife Inc (NYSE:MET). The Florida-based Carl Domino has invested 0.75% in Metlife Inc (NYSE:MET). Bridgewater Ltd Partnership holds 0.21% of its portfolio in Metlife Inc (NYSE:MET) for 415,045 shares. Wedge Mgmt L Lp Nc accumulated 0.23% or 556,314 shares. Moreover, Ledyard Bank has 0.03% invested in Metlife Inc (NYSE:MET) for 4,735 shares. Fort Washington Inv Advisors Oh has invested 0.13% of its portfolio in Metlife Inc (NYSE:MET). Private Management Gru reported 939,605 shares or 2.46% of all its holdings. Salient Cap Advsrs Lc has 13,816 shares for 0.01% of their US portfolio. Parametric Portfolio Assoc Ltd holds 0.2% of its portfolio in Metlife Inc (NYSE:MET) for 3.24 million shares.

More notable recent Metlife Inc (NYSE:MET) news were published by: which released: “MetLife opts for spinoff of life insurance operations” on October 05, 2016, also with their article: “MetLife to Hold Investor Day” published on September 28, 2016, published: “Fitch Affirms MetLife, Inc. and Most Subsidiaries” on September 13, 2016. More interesting news about Metlife Inc (NYSE:MET) were released by: and their article: “MetLife Named to Working Mother “100 Best Companies” List for 18th Year in a Row” published on September 27, 2016 as well as‘s news article titled: “MetLife, Norges Bank Venture Buys Washington Office Complex” with publication date: September 22, 2016.

MET Company Profile

MetLife, Inc. (MetLife), incorporated on August 10, 1999, is a well-known provider of life insurance, annuities, employee benefits and asset management. The Company’s divisions include Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America (collectively, the Americas); Asia, and Europe, the Middle East and Africa (EMEA). In addition, MetLife’s Corporate & Other contains the surplus portfolios for the enterprise, the portfolios used to fund the capital needs of the Company and various reinsurance agreements. In the United States, the Company provides a range of insurance and financial services products, including life, dental, disability, property and casualty, guaranteed interest, stable value and annuities, through both proprietary and independent retail distribution channels, as well as at the workplace. Outside the United States, the Company provides life, medical, dental, credit and other accident and health insurance, as well as annuities, endowment and retirement and savings products to both individuals and groups.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment